Burn News and Research

RSS

Study reveals safety of ConvaTec's advanced antimicrobial dressing

ConvaTec, a world-leading provider of innovative medical technologies for community and hospital care, today announced new data showing that AQUACEL(R) Ag, the company's advanced antimicrobial dressing, is safe for use in an MRI environment.

25 Aug 2009

Celsius Holdings introduces calorie burning beverage in New York and Pennsylvania

Celsius Holdings, Inc. (OTCBB: CSUH) announced today that Celsius®, the original calorie burning beverage, is now available at all 76 Tops Friendly Markets locations in New York and Pennsylvania.

25 Aug 2009

Neurogen stockholders to receive $11 million in Ligand Pharmaceuticals common stock as part of acquisition deal

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights (“CVRs”) under four CVR agreements.

25 Aug 2009

American Council on Exercise reveals fitness and nutrition tips for students

As students all across the country flock to college campuses this month, The American Council on Exercise (ACE), America's leading authority on fitness and one of the largest fitness certification, education and training organizations in the world, today revealed its top ten fitness and nutrition tips for remaining in good health for the 2009 school year.

22 Aug 2009

Coping with burn injuries

More than half a million Americans are treated for burn injuries every year, but many do not have the specific skills necessary to cope with the experience of living with a burn injury after they leave the hospital.

20 Aug 2009

DNA-encased carbon nanotubes used for treating human prostate cancer tumors in mice

Researchers at Wake Forest University School of Medicine have destroyed prostate cancer tumors in mice by injecting them with specially-coated, miniscule carbon tubes and then superheating the tubes with a brief zap of a laser.

20 Aug 2009

Arpida reports financials for the six months ending 30 June 2009

CFO Harry Welten, MBA, commented: "Our cost-saving measures have been implemented, resulting in a substantial reduction of the cash burn. We expect to have cash and financial investments of around CHF 14 million at the end of 2009."

19 Aug 2009

Researchers find connection between eye disease and arginase

Elevated levels of the enzyme arginase contribute to vascular eye damage and Medical College of Georgia researchers say therapies to normalize its levels could halt progression of potentially blinding diseases such as diabetic retinopathy.

19 Aug 2009

Novavax reports positive preclinical results for H1N1 influenza VLP vaccine

Novavax, Inc. (Nasdaq: NVAX) announced positive preclinical results with Novavax's 2009 novel H1N1 influenza virus-like particle (VLP) vaccine. The study, conducted by scientists from Novavax and the Centers for Disease Control and Prevention (CDC) based in Atlanta, GA, under a collaborative agreement, represents the first efficacy report of a 2009 novel H1N1 vaccine in ferrets. The ferret model is widely accepted to be the most appropriate animal model for evaluating influenza disease and vaccines. Novavax scientists designed the vaccine using recombinant virus like particles (VLP) technology against an H1N1 virus strain (A/California/04/2009) isolated in the beginning of the 2009 H1N1 outbreak.

19 Aug 2009

FDA approves Helixate FS for routine prophylaxis in children with hemophilia A

CSL Behring announced today that Helixate® FS, Antihemophilic Factor (Recombinant), has been approved by the U.S. Food and Drug Administration (FDA) for routine prophylaxis in children with hemophilia A who are 16 years old or younger and do not have pre-existing joint damage.

17 Aug 2009

Possible neurological complications of heart surgery detailed in new report

In the most comprehensive and up-to-date review of its kind, researchers list possible nervous system complications of bypass surgeries, aortic surgery, cardiac catheterizations, valve replacements, heart transplants and surgeries for congenital heart disease and heart tumors.

13 Aug 2009

Neurological complications of heart surgery detailed in research

Possible neurological complications of heart surgery, ranging from headaches to strokes, are detailed in a new report in the online journal MedLink Neurology.

13 Aug 2009

Innovative projects addressing childhood obesity

Youth Service America (YSA) and UnitedHealth Group team up for the second year to offer UnitedHealth HEROES grants to youth-led service-learning projects addressing childhood obesity.

10 Aug 2009

Lasers and nanotubes offer potential future cancer treatments

By injecting man-made, microscopic tubes into tumors and heating them with a quick, 30-second zap of a laser, scientists have discovered a way to effectively kill kidney tumors in nearly 80 percent of mice. Researchers say that the finding suggests a potential future cancer treatment for humans.

3 Aug 2009

Seven out of ten U.S. children low in vitamin D

Seven out of ten U.S. children have low levels of vitamin D, raising their risk of bone and heart disease, according to a study by researchers at Albert Einstein College of Medicine of Yeshiva University. The striking findings suggest that vitamin D deficiency could place millions of children at risk for high blood pressure and other risk factors for heart disease.

3 Aug 2009

Spermatagonial stem cells can be directly converted into other cell types

Researchers have found a way to directly convert spermatogonial stem cells, the precursors of sperm cells, into tissues of the prostate, skin and uterus. Their approach, described this month in the journal Stem Cells, may prove to be an effective alternative to the medical use of embryonic stem cells.

28 Jul 2009

Nanoparticle antimicrobial gel formulation for topical use

Scientists in India are reporting successful laboratory tests of a new and potentially safer alternative to silver-based gels applied to the skin of burn patients to treat infections.

26 Jul 2009

Obesity increases risk of complications in pregnancy

Expectant mothers who are obese are much more likely to suffer from minor complications such as heart burn and chest infections during pregnancy, a study suggests.

16 Jul 2009

"Drops" of gold that burn tumors

At a technical breakfast, Romain Quidant presented his research into the detection and treatment of cancer using gold nanoparticles illuminated with laser light. Quidant, who was recently awarded the Fresnel Prize 2009 that recognizes the highest level of excellence amongst emerging researchers in the field of photonics, is an ICREA researcher at the UPC's Institute of Photonic Sciences (ICFO) and a fellow of the Cellex Foundation Barcelona.

16 Jul 2009

Minnesota delegation wary of proposed health care reform

"Here's a little secret you might not know about the health care reform being debated in Washington: Minnesota might not want it," Minnesota Public Radio reports.

15 Jul 2009